WHOOP launches clinician video visits, EHR integration with HealthEx

mobihealthnews.com·May 12, 2026

WHOOP has introduced new AI features, including on-demand video consultations with licensed medical clinicians for U.S. users and EHR syncing through a partnership with HealthEx.

The integration of AI features, on-demand video consultations, and EHR syncing by WHOOP highlights a significant trend towards holistic digital health solutions, offering an investment opportunity in platforms that combine wearables with telemedicine and health data integration for enhanced user engagement and personalized care.

Want more content like this?

twixb tracks your favorite blogs and social media, filters by keywords, and delivers personalized key learnings — straight to your inbox.

Create Your Own →Explore Newsfeeds

More from Healthtech & Biotech News

Recent stories curated alongside this one.

mobihealthnews.com
Owkin, AstraZeneca expand collaboration on AI-driven drug research tools
Owkin has signed a three-year licensing agreement with AstraZeneca for its AI Scientist platform, K Pro, which is aimed at enhancing pharmaceutical research and decision-making.
endpts.com
Abeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3
Abeona Therapeutics has shifted its focus from eye gene therapies to developing solid tumor T cell therapies, while also providing updates on companies including Amicus Therapeutics, Fosun Pharma, Duality Biotherapeutics, BioNTech, and C4 Therapeutics.
statnews.com
STAT+: Gene therapy viruses linked to a boy’s tumor
Marty Makary has officially resigned as FDA commissioner, with Kyle Diamantas appointed as the acting commissioner, as confirmed by President Trump.
fiercebiotech.com
<a href="https://www.fiercebiotech.com/cro/icon-opens-early-phase-research-unit-san-antonio-satellite-clinics-grow-trial-capabilities" hreflang="en">Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities</a>
Icon, a global contract research organization, has opened a new research facility in San Antonio, Texas, and established satellite clinics in Houston and Lawrence, Kansas, to enhance its clinical trial capabilities.
statnews.com
STAT+: Hims’ sales miss as telehealth competition grows
A new series has been launched investigating the alcohol epidemic in the U.S., focusing on industry influences and treatment gaps. Additionally, Rigel Pharma has partnered with Arvinas and Pfizer to market a new breast cancer drug, Roche has received European clearance for an early Alzheimer's blood test, and BridgeBio has submitted an FDA application for a drug to treat a rare genetic disease.

Browse all Healthtech & Biotech News →

WHOOP launches clinician video visits, EHR integration with HealthEx

Want more content like this?

More from Healthtech & Biotech News

Owkin, AstraZeneca expand collaboration on AI-driven drug research tools

Abeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3

STAT+: Gene therapy viruses linked to a boy’s tumor

<a href="https://www.fiercebiotech.com/cro/icon-opens-early-phase-research-unit-san-antonio-satellite-clinics-grow-trial-capabilities" hreflang="en">Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities</a>

STAT+: Hims’ sales miss as telehealth competition grows